Calamos Advisors LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 45 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2017$17,000
+6.2%
13,1960.0%0.00%
Q1 2017$16,000
-20.0%
13,196
+32.0%
0.00%
Q4 2016$20,000
-42.9%
10,0000.0%0.00%
Q3 2016$35,00010,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$5,616,219,0004.42%
CARL DOMINO INC 112,719$142,0000.16%
VAN DEN BERG MANAGEMENT I, INC 243,679$307,0000.04%
ELEMENT CAPITAL MANAGEMENT LLC 112,735$142,0000.03%
Psagot Value Holdings Ltd. 195,999$247,0000.01%
ORACLE INVESTMENT MANAGEMENT INC 50,804$64,0000.01%
B. Riley Wealth Advisors, Inc. 28,927$37,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 18,894$24,0000.01%
WEALTHSOURCE PARTNERS, LLC 10,000$13,0000.00%
LMR Partners LLP 50,168$63,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders